Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ: ZNTL · Real-Time Price · USD

3.705

+0.145 (4.07%)

At close: Aug 17, 2026, 4:00 PM EDT

3.770

+0.065 (1.75%)

After-hours: Aug 17, 2026, 7:55 PM EDT

Zentalis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.78	36	33.9	28.04	43.07	59.71
Short-Term Investments	149.83	209.9	337.18	454.88	394.3	280.17
Cash & Short-Term Investments	174.61	245.89	371.08	482.92	437.37	339.89
Cash Growth	-42.45%	-33.74%	-23.16%	10.41%	28.68%	0.41%
Accounts Receivable	-	-	5	-	-	-
Receivables	-	-	5	-	-	-
Prepaid Expenses	6.67	7.3	9.98	13.8	14.56	10.64
Restricted Cash	-	-	-	-	-	0.24
Total Current Assets	181.28	253.19	386.07	496.72	451.93	350.77
Property, Plant & Equipment	27.3	29.04	37.23	41.74	50.08	52.84
Long-Term Investments	-	-	-	-	21.21	37.5
Goodwill	-	-	-	3.74	3.74	3.74
Other Long-Term Assets	6.76	6.74	7.04	9.5	12.35	9.67
Total Assets	215.33	288.97	430.34	551.69	539.31	454.51

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	8.14	7.21	7.44	14.93	11.25	11.59
Accrued Expenses	25.27	25.28	42.22	51.54	42.85	29.93
Current Portion of Leases	4.13	3.87	3.07	2.62	2.16	1.45
Current Income Taxes Payable	0.08	0.19	-	0.28	0.38	0.97
Total Current Liabilities	37.63	36.56	52.73	69.37	56.65	43.94
Long-Term Leases	33.56	35.7	39.58	43.15	45.17	44.46
Long-Term Deferred Tax Liabilities	-	-	-	-	0.85	1.62
Other Long-Term Liabilities	0.5	0.5	0.85	1.78	2.62	-
Total Liabilities	71.68	72.76	93.15	114.3	105.29	90.03

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.07	0.07	0.07	0.07	0.06	0.05
Additional Paid-In Capital	1,413	1,407	1,391	1,324	1,031	723.59
Retained Earnings	-1,269	-1,191	-1,054	-888.56	-596.37	-359.56
Comprehensive Income & Other	-0.08	0.2	0.56	2.19	-1.35	-0.13
Total Common Equity	143.65	216.2	337.19	437.28	433.8	363.95
Minority Interest	-	-	-	0.11	0.22	0.53
Shareholders' Equity	143.65	216.2	337.19	437.39	434.02	364.48
Total Liabilities & Equity	215.33	288.97	430.34	551.69	539.31	454.51

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	37.69	39.58	42.65	45.77	47.33	45.91
Net Cash (Debt)	136.92	206.32	328.44	437.15	390.04	293.98
Net Cash Growth	-47.76%	-37.18%	-24.87%	12.08%	32.68%	-12.64%
Net Cash Per Share	1.92	2.87	4.62	6.68	7.38	6.89
Filing Date Shares Outstanding	71.67	70.93	71.81	70.96	59.42	45.56
Total Common Shares Outstanding	71.67	69.09	71.28	70.77	59.28	45.49
Working Capital	143.65	216.63	333.34	427.35	395.29	306.83
Book Value Per Share	2.00	3.13	4.73	6.18	7.32	8.00
Tangible Book Value	143.65	216.2	337.19	433.55	430.07	360.22
Tangible Book Value Per Share	2.00	3.13	4.73	6.13	7.25	7.92
Machinery	1.4	1.38	4.81	4.56	4.84	4.39
Construction In Progress	-	-	-	0.17	0.04	0.03
Leasehold Improvements	4.17	4.17	4.17	4.24	4.89	4.52

SEC Filings: 10-K · 10-Q